e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Malignant pleural mesothelioma: Current status and future projections in Turkey
A. Salih Emri (Ankara, Turkey), Ozge Yavuz, Salih Emri
Source:
International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Session:
Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Session type:
Thematic Poster Session
Number:
4317
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Salih Emri (Ankara, Turkey), Ozge Yavuz, Salih Emri. Malignant pleural mesothelioma: Current status and future projections in Turkey. Eur Respir J 2015; 46: Suppl. 59, 4317
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Late Breaking Abstract - Developing the pneumonia-optimized ratio for community-acquired pneumonia: an easy, inexpensive and accurate prognostic biomarker
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Pleural mesothelioma: Our experience in 132 cases
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014
Solitary fibrous tumour of the pleural: Two malignant cases
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
Source: Guideline 2010
Year: 2010
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
Source: Eur Respir J 2010; 35: 479-495
Year: 2010
A requirement for kras signaling in malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013
Haematologic parameters and their prognostic impact in malignant pleural mesothelioma
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Malignant pleural effusion as the initial manifestation of gynecological malignancies
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
The role of a pleural service in optimising pleural disease management
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
A novel pleural-bladder pump for management of pleural effusion
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
Malignant mesothelioma vs metastatic carcinoma of pleura: Do pathology and radiology agree?
Source: Annual Congress 2013 –Morphologic imaging
Year: 2013
CT scanner for the pleural staging of pleural cancer: How accurate is this?
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Characteristics of malignant pleural effusions. Review of one-year data from a large tertiary centre
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013
Sclerosing hemangioma of the lung: Report of 4 cases
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Role of tumor derived versican in experimental malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016
Survival analysis of pleural malignant mesothelioma (MM) at a single Institution in Liguria, Italy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Primary melanoma of bronchus: Report of 4 cases
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Pericardiodesis in pericardial tamponade
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE)
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
A myeloid NF-κbeta response in malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept